Ekinokokkoz; Kist Hidatik

Year 2019, Volume: 11 Issue: 6, 292 - 297, 01.12.2019

Sevgen Tanır Başaranoğlu Ateş Kara

Abstract

Ekinokokkoz insanlarda Echinococcus cinsinin sestodlarının larva formlarının sebep
olduğu enfeksiyon nedeniyle gelişmektedir. Tanısal çalışmalar ve tedavi yaklaşımı
açısından çok yol katedilmiş olmasına rağmen, birçok çalışma halen dünya çapında
ekinokokkozun ciddi bir halk sağlığı problemi teşkil ettiğini göstermektedir.

Keywords

Kistik ekinokokkoz, alveolar ekinokokkoz, tanı, tedavi, önlem

References

• 1. McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362: 1295-304.
• 2. Craig PS, McManus DP, Lightowlers MW, et al. Prevention and control of cystic echinococcosis. Lancet Infect Dis 2007; 7: 385-94.
• 3. Brunetti E, Junghanss T. Update on cystic hydatid disease. Curr Opin Inf Dis 2009; 22: 497-502.
• 4. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107-35.
• 5. Tappe D, Zidowitz S, Demmer P, Kern P, Barth TF, Frosch M. Three-dimensional reconstruction of Echinococcus multilocularis larval growth in human hepatic tissue reveals complex growth patterns. Am J Trop Med Hyg 2010; 82 (1): 126-27.
• 6. Jenkins EJ, Peregrine AS, Hill JE, et al. Detection of European Strain of Echinococcus multilocularis in North America. Emerg Infect Dis 2012; 18 (6): 1010-12.
• 7. Ammann R, Eckert J. Cestodes: Echinococcus. Gastroenterol Clin N Am 1996; 25: 655–89.
• 8. Pawlowski Z, Eckert J, Vuitton DA, et al. Echinococcosis in humans: clinical aspects, diagnosis and treatment. In: Eckert
• J, Gemmell MA, Meslin FX, Pawlowski Z, eds. WHO/OIE Manual on Echinococcosis in humans and animals. Paris: Office International des Épizooties; 2001: 20-71.
• 9. Zhang W, McManus DP. Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunol Med Microbiol 2006; 47: 24—41.
• 10. Carmena D, Benito A, Eraso E. The immunodiagnosis of Echinococcus multilocularis infection. Clin Microbiol Infect 2007; 13: 460-75.
• 11. Smego Jr RA, Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis 2005; 9: 69-76.
• 12. Cobo F, Yarnoz C, Sesma B, et al. Albendazole plus praziquantel versus albendazole alone as a pre- operative treatment in intra-abdominal echinococcosis caused by Echinococcus granulosus. Trop Med Int Health 1998; 3: 462—66.
• 13.Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009; 13 (2): 125-33.
• 14. Khuroo MS, Dar MY, Yattoo GN, Shah AH, Jeelani SG. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a perspective, randomized study. Gastroenterology 1993; 104: 1452-59.
• 15. Koch S, Bresson-Hadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a
• 45-case European collaborative report. Transplantation 2003; 75: 856—63.
• 16. Lightowlers M, Jensen O, Fernandez E, et al. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int J Parasitol 1999; 29: 531–34.
• 17. Zhang W, Zhang Z, Shi B, et al. Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans. J Infect Dis 2006; 194: 966—74.
• 18. Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004; 17: 107—35.
• Bu Makale Klinik Tıp Pediatri Dergisi’nin Cilt 8 Sayı 4 Temmuz - Ağustos 2016 saysından alınarak tıpkısının aynısı olarak yayınlamıştır.